Related Experiment Video

Updated: Apr 21, 2026

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.5K

UNC51-like kinase 1, autophagic regulator and cancer therapeutic target

Y Chen1, J He, M Tian

  • 1State Key Laboratory of Biotherapy & Collaborative Innovation Center of Biotherapy, Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China.

Cell Proliferation
|October 21, 2014
PubMed

Insights

Autophagy is a cellular process crucial for energy balance. The study explores how UNC-51-like kinase 1 (ULK1) regulates autophagy in cancer, suggesting ULK1 as a potential therapeutic target.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Autophagy, a cellular self-digestion process, is vital for maintaining cellular homeostasis and protein synthesis.
  • Autophagy's role in cancer is complex, potentially protecting against or promoting cell death.
  • The autophagy-related gene (Atg) family, including yeast Atg1 and its mammalian homolog ULK1, regulates autophagosome formation.

Purpose of the Study:

  • To summarize the properties of UNC-51-like kinase 1 (ULK1) in regulating autophagy.
  • To explore ULK1's dual role in cancer suppression and promotion.
  • To highlight ULK1 as a potential therapeutic target in cancer therapy.

Main Methods:

  • Review of existing literature on ULK1 function in autophagy and cancer.
  • Analysis of ULK1's interactions with other autophagy-related proteins (e.g., mAtg13, FIP200).
  • Discussion of post-translational modifications and signaling pathways involving ULK1.

Main Results:

  • ULK1, a mammalian homolog of yeast Atg1, mediates autophagy.
  • ULK1 and its complex (ULK1-mAtg13-FIP200) are involved in autophagy under nutrient deprivation.
  • ULK1 exhibits a dual role in cancer, capable of both suppressing and promoting tumor growth.

Conclusions:

  • ULK1 plays a significant role in regulating autophagy in cancer.
  • Understanding ULK1's mechanisms could lead to novel cancer therapy strategies.
  • ULK1 represents a promising target for future cancer treatments.

More Related Videos

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

1.3K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.9K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
6.9K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
7.6K